How many drugs are approved by EMA?

overview of its key recommendations in 2020 on the authorisation and safety monitoring of medicines for human use. In 2020, EMA recommended 97 medicines for marketing authorisation. Of these, 39 had a new active substance which had never been authorised in the European Union before.

Are Covid vaccines EMA approved?

COVID-19 vaccines authorised for use in the EU, following evaluation by EMA, with links to detailed information on each authorised vaccine. COVID-19 vaccines reviewed for use in the EU under Article 5(3) of Regulation 726/2004.

How new drugs are approved in Europe?

The current European system of medicines approval consists of a centralised authorisation procedure as well as national authorisation procedures based on simultaneous authorisation in more than one European Union (EU) Member State and the mutual recognition of marketing authorisations.

Can you use the central MAA process for a generic drug?

However, a generic application based on a nationally authorised reference medicinal product can only be processed via the centralised procedure after expiry of a 10-year period of protection if the reference product chosen by the applicant is also authorised in Member States where a ten-year period of protection …

What is a new drug application called in Europe?

In the United States, the initial submission to permit use of an investiga- tional drug in a clinical setting is called an investigational new drug (IND) application. In the European Union, this documen- tation is submitted within a clinical trial application (CTA).

WHO approved drugs in Germany?

The Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte or BfArM) is the medical device regulatory authority in Germany.

Who approves drugs in the EU?

The European Commission
The European Commission is the authorising body for all centrally authorised product, who takes a legally binding decision based on EMA’s recommendation. This decision is issued within 67 days of receipt of EMA’s recommendation.

Does Norway follow EMA?

This decision is issued within 67 days of receipt of EMA’s recommendation. Once granted by the European Commission, the centralised marketing authorisation is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway.

Is the EMA better than the FDA?

The study results show that, in the time period between 2011 and 2015, the FDA approved 170 new drugs while the EMA approved only 144. Furthermore, the FDA had a median review time of 306 days, while, at the EMA, there was a median review time of 383 days.